Information For Authors
- Author Benefits Program
- Manuscript Submission Guidelines
- Open Access Policy
- NIH/HHMI Wellcome Trust Policies
- Self-Archiving Policy
Sustainability: The Journal of Record is committed to providing a legitimate platform for sustainability researchers, change agents, and stakeholders to present original work, and express and exchange ideas in this increasingly important field.
The Journal accepts research-based manuscripts for review as well as best practice case studies, and perspectives and commentary on newsworthy trends shaping sustainability in the culture.
Some of the focus topics for authors to consider include (but are not limited to): programs to address climate change; energy, water, and resource conservation; behavior modification programs; the impact of change agents; bringing diversity into the sustainability field; melding budget cuts and sustainability; the built environment; green workforce development; best practice case studies from higher education, nonprofits, and the private sector; and sustainable agriculture and food programs.
Manuscripts submitted to this Journal must not be under consideration elsewhere.
Sustainability: The Journal of Record invites authors to submit all new manuscripts to be considered for publication via our online submission site: https://mc.manuscriptcentral.com/sustainability
Please read all instructions carefully before beginning your submission.
Create an Account in Manuscript Central
If you do not already have an account in Manuscript Central for Sustainability: The Journal of Record, you will need to create one. Once your account is created, you may log in to the system to begin your submission. NOTE: Each listed author on a submission must either have an account, or have one created, in the submission system.
Authors must include the paper’s title, corresponding author’s name, address, institutional affiliation(s), a telephone and email address. The cover letter should indicate that the work has not previously been published, is not under consideration for publication elsewhere, that all authors have read and agree with the contents of the submission, and that all authors have contributed substantially to the work.
It is incumbent upon the submitting author and/or agent to ensure the accuracy and inclusion of all contributing authors’ names and affiliations upon original submission of the paper. Once a paper is accepted for publication, changes in authorship – including the page proof stage – are not permitted. Changes in authorship after publication are strictly prohibited.
It is the Journal’s policy that a manuscript has only ONE corresponding author listed on a paper. This designation should be determined at the time of submission. Additions to corresponding authors are not permitted after acceptance or in page proofs.
It is permissible to list two authors as co-first authors. Include an asterisk (*) next to the authors’ names who are considered as first authors. Include a corresponding footnote, using the asterisk, on the title page that reads, “These authors contributed equally to this work and are considered to be co-first authors.”
Working Groups as Authors
Working Groups, Teams, or Committees may be listed in the manuscript byline, but the complete list of members' names must be included in the acknowledgment section of the manuscript, stating, "Members of the ABC Committee are..." Do not list the names in a footnote on the title page.
For manuscripts with multimedia components, either in their preparation or accompanying the print article, including but not limited to podcasts and videocasts, the multimedia author(s) should be listed with the other contributing authors on the manuscript and also must have an account in the manuscript submission system.
PREPARATION OF MANUSCRIPTS
Use of English Language
All submissions must be in English. Appropriate use of the English language is a requirement for review and publication in Sustainability: The Journal of Record. For authors whose native language is not English, we suggest using a service that can aid in the translation and rewriting of material into correct and proper English usage. The Publisher offers this service with a subsidy from the author prior to official submission. It is important to note that employing the use of the Publisher’s service does not guarantee acceptance of any paper. All submissions are subject to peer review. For information on this service, please contact: Editing@liebertpub.com
Original manuscripts submitted for peer review may not exceed 3,000 words, not including abstracts, acknowledgments, disclosures, or references, or figure legends. Submissions of manuscripts must be double-spaced.
Requirements for Title Page
The title page of your submission must be included as part of your main text document (not as a separate file) and must include the following items:
- The complete title of the article;
- ALL contributing authors’ full names, complete affiliation and mailing address, full contact information (telephone and e-mail address).
- A brief running title of no more than 45 characters, including spaces
- The corresponding author’s complete contact information including address and valid e-mail address.
- Three (3) to six (6) keywords for searchability
Please follow this sequence of sections within the manuscirpt:
- Abstract: 250 words or less, without the use of subheadings. Reference citations or proprietary product information is not permitted in the abstract.
- Introduction: Summarize the background of the technology and its significance and novelty. Results should NOT be included in the introduction.
- Materials and Methods: Specific products and materials should be specified, marked with ™ or ® if they are trademarked or registered. These notations need only be cited at a product’s first mention in the text. All acronyms and their definitions should be spelled out in a separate list on a separate page immediately after the title page. Use only acronyms in text. When using specific brand names, please include the manufacturer’s name and location (including city and state) in parentheses.
- Discussion: The results and discussion sections of short papers may be combined for more effective presentation.
- Author Disclosure Statement.
- Use Arabic numerals to number tables. Cite tables consecutively in text.
- Do not repeat information that is given in the text, and do not make a table for data that can be given in the text in one or two sentences.
- Provide titles for all tables.
- Define all acronyms in table footnotes. All other types of table footnotes should be designated using superscript letters, not symbols.
- Do not include any figures in the main text file.
- Each figure should be provided as individual files, not together in one file.
- Figures should be prepared in .TIFF or .EPS format. Do not prepare figures in Word. Do not upload figures in PDF format.
- Figures should be numbered in the order cited in the text.
- Images should not show the name of a manufacturer or reveal patient names.
- All symbol definitions should be in figure legend, not as a key within the figure.
- If possible please use Arial font for figure text.
- Reprinted or adapted figures from previously published sources must be appropriate credited, and permission must be secured by the author(s) from the original publisher.
Name figure files using only alphanumeric characters. Do not use symbols, dots, or dashes.
File names should be formatted with first author’s last name and the figure number. (Ex: SmithFig1)
- Line and bar graphs should be submitted at a minimum of 900 dpi.
- Color and gray scale images/photos/figures should be submitted at a minimum of 300 dpi.
- Color images should be saved in CYMK mode (not RGB).
COLOR PUBLICATION OF FIGURES
Color publication of figures is encouraged, but the cost of color printing must be subsidized by the author(s). Please contact the Publisher at AuthorBenefitsProgram@liebertpub.com for pricing information.
- Supply a figure legend for each figure in the submission
- Figure legends must be compiled and supplied as a separate Word document, double spaced, and uploaded as a separate file from the main text file.
Please keep in mind that the figures will be reduced, so please do not submit large figures/graphs that contain small type, as the text within the figure will not be readable after reduction.
AUTHOR DISCLOSURE STATEMENT
Immediately following the Acknowledgments section, include a section entitled “Author Disclosure Statement.” In this portion of the paper, authors must disclose any commercial associations that might create a conflict of interest in connection with submitted manuscripts. This statement should include appropriate information for EACH author, thereby representing that competing financial interests of all authors have been appropriately disclosed according to the policy of the Journal. It is important that all conflicts of interest, whether they are actual or potential, be disclosed. This information will remain confidential while the paper is being reviewed and will not influence the editorial decision. Please see the Uniform Requirements for Manuscripts Submitted to Biomedical Journals at http://www.icmje.org/index.html#conflicts for further guidance.
If no conflicts exist, the authors must state “No competing financial interests exist."
- All references must be cited in the text using a superscript Arabic number.
- Arrange the reference list in numeric order as cited in the text.
- Abbreviate journal names according to Serial Sources for the BIOSIS Data Base (BioSciences Information Service, 1992).
References should be presented in the following style:
Journal citation: Rowe D. Sustainability: Education for a sustainable future. Science 2007;317:323-324..
Book citation: Blackburn WR. The Sustainability Handbook: The Complete Management Guide to Achieving Social, Economic and Environmental Responsibility. Environmental Law Institute, Washington, DC, 2007.
Website: Author [if known]. Name of web page. Web address. (Last accessed on [date]).
When dates from an unpublished source are given, supply the researcher’s name. If the work is in press, give the journal in which it is to be published.
PUBLICATION ETHICS AND MALPRACTICE STATEMENT
Study Design and Ethics
Documented review and approval from a formally constituted review board (Institutional Review Board or Ethics committee) should be required for all studies involving people, medical records, and human tissues. For those investigators who do not have access to formal ethics review committees, the principles outlined in the Declaration of Helsinki should be followed. If the study is judged exempt from review, a statement from the committee should be required. Informed consent by participants should always be secured. If not possible, an institutional review board must decide if this is ethically acceptable. This information should be outlined in the cover letter accompanying the submission, and a sentence declaring adherence should be included in the acknowledgment section of the manuscript.
Animal experiments should require full compliance with local, national, ethical, and regulatory principles, and local licensing arrangements.
Definitions of Scientific Misconduct
Mary Ann Liebert, Inc., publishers generally follows the guidelines and rules regarding scientific misconduct put forth by the Committee on Publication Ethics (COPE), the International Committee of Medical Journal Editors (ICMJE), and the Office of Research Integrity (ORI).
Scientific misconduct and violation of publishing ethics vary and can be intentionally or unintentionally perpetrated. Some examples of misconduct and violations include, but are not limited to, the following:
- Scientific Misconduct: Fabrication, falsification, concealment, deceptive reporting, or misrepresentation of any data constitutes misconduct and/or fraud.
Authorship Disputes: Deliberate misrepresentation of a scientist’s contribution to the published work, or purposefully omitting the contributions of a scientist.
Misappropriation of the ideas of others: Improper use of scholarly exchange and activity may constitute fraud. Wholesale appropriation of such material constitutes misconduct.
Violation of generally accepted research practices: Serious deviation from accepted practices in proposing or carrying out research, improper manipulation of experiments to obtain biased results, deceptive statistical or analytical manipulations, or improper reporting of results constitutes misconduct and/or fraud.
Material failure to comply with legislative and regulatory requirements affecting research:
Including but not limited to serious or substantial, repeated, willful violations of applicable local regulations and law involving the use of funds, care of animals, human subjects, investigational drugs, recombinant products, new devices, or radioactive, biologic, or chemical materials constitutes misconduct.
- Conflict of Interest: Nondisclosure of any conflicts, direct or indirect, to the Journal which prevents you from being unbiased constitutes misconduct.
- Deliberate misrepresentation: of qualifications, experience, or research accomplishments to advance the research program, to obtain external funding, or for other professional advancement constitutes misconduct and/or fraud.
Plagiarism: Purposely claiming another’s work or idea as your own constitutes misconduct and/or fraud.
- Simultaneous Submission: Submitting a paper to more than one publication at the same time constitutes misconduct.
Responding to Allegations of Possible Misconduct
The Publisher is committed to helping protect the integrity of the public scientific record by sharing reasonable concerns with authorities who are in the position to conduct an appropriate investigation into an allegation. As such, all allegations of misconduct will be referred to the Editor-In-Chief of the Journal who in turn will review the circumstances, possibly in consultation with associate editors and/or members of the editorial board. Initial fact-finding will usually include a request to all the involved parties to state their case and explain the circumstances in writing. In questions of research misconduct centering on methods or technical issues, the Editor-In-Chief may confidentially consult experts who are blinded to the identity of the individuals, or if the allegation is against an editor, an outside expert. The Editor-In-Chief will arrive at a conclusion as to whether there is enough reasonable evidence that the possibility of misconduct occurred.
When allegations concern authors, the peer review and publication process for the manuscript in question will cease while the process described herein is researched. The investigation will be taken to completion even if the authors withdraw their paper. In the case of allegations against reviewers or editors, they will be replaced in the review process while the matter is investigated.
Editors or reviewers who are found to have engaged in scientific misconduct will be removed from further association with the Journal, and reported to their institution.
If an inquiry concludes there is a reasonable possibility of misconduct, the Editor-in-Chief will retract the paper from the Journal and the scientific record. If the paper is still under peer review, the Editor-in-Chief will withdraw the paper from consideration to the Journal.
All allegations will be kept confidential.
Upon acceptance of any manuscript processed through Manuscript Central, all authors will receive a follow-up email with instructions on completing our online Copyright Agreement form. Each author will receive individualized links to their copyright form. Authors will not be permitted to “share” or forward these individualized links as they are unique to each author. Therefore, it is critical to ensure the accuracy of ALL authors’ email addresses when uploading submissions to ensure the proper delivery of each copyright form, and any other pertinent email communications.
The corresponding author is responsible for communicating with coauthors to ensure they have completed the online copyright form. Authors not permitted to release copyright must still return the form acknowledging the statement of the reason for not releasing the copyright.
Failure by all authors to submit this form will result in a delay in publication.
- The author must obtain written permission from the publisher of the journal or book concerned for the reproduction of figures, tables, etc. from copyrighted materials.
- The publication from which the figure or table is taken must be listed as a reference in the reference list.
- An appropriate credit line should be included in the figure legend or table footnote, and full publication information should be included in the reference list.
Page proofs are sent to the corresponding author via e-mail. Please ensure that current e-mail addresses are provided with the manuscript. The Publisher requests that page proofs containing corrections be returned to the Publisher within 72 hours of receipt. If the corresponding author expects to be unavailable at the time proofs are anticipated, please notify the Publisher and provide an alternate corresponding author and e-mail address.
Reprints may be ordered by following the special instructions that will accompany page proofs, and should be ordered at the time the corresponding author returns the corrected page proofs to the Publisher. Reprints ordered after an issue is printed will be charged at a substantially higher rate. Contact Reprints@liebertpub.com
Sustainability: The Journal of Record is owned and published by Mary Ann Liebert, Inc., publishers, 140 Huguenot Street, 3rd Floor, New Rochelle, NY 10801-5215. Telephone: (914) 740-2100; Fax: (914) 740-2101; Email: firstname.lastname@example.org; Online: home.liebertpub.com
Ensure maximum visibility, discoverability, and impact for your article with our Liebert Open Access (OA) option
Does your research funder have an open access mandate or would you like to expand the dissemination of your research?
The Liebert Open Access option enables authors to publish open access in our esteemed subscription-based journals.
The benefits of Liebert Open Access include:
- High visibility; open access articles are freely available online upon publication
- You retain copyright with the open access license allowing broad dissemination of your research
- You can freely share your article in repositories and research networks without restrictions
- Easy compliance with open access mandates
- Rigorous editorial and peer-review
- Targeted email announcement featuring a direct link to article
Identification and Marketing
Open access articles are listed with an OA icon in journal tables of content (TOC), TOC alerts, and in marketing announcements. Open access articles are highlighted and promoted in targeted email announcements to thousands of research leaders in your field.
Copyright and Licensing
If you choose to publish with open access, you will retain copyright of your article and a Creative Commons license will be applied. The liberal Creative Commons Attribution 4.0 (CC-BY) license is the default open access license used at Mary Ann Liebert, Inc., publishers. The CC-BY license permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
At this time we allow authors to choose between the CC-BY or CC-BY-NonCommercial license. A limited number of journals offer NonCommercial licenses exclusively.
Ordering Open Access
Once your article has been accepted for publication in a journal, you will receive an email with information on ordering Liebert Open Access. If you would like more information about Liebert Open Access or would like to order open access, please email email@example.com.
Publishing open access includes an article publication charge (APC) and authors are asked to fill out a short open access order form. You can pay by credit card or receive an invoice to be returned with payment or via bank transfer. Please remember that traditional subscription journals can carry mandatory or optional author fees. The Liebert Open Access APC does not cover or replace existing publication or author fees.
Publishing biomedical or biotechnology research?
Biomedical researchers should consider publishing in BioResearch Open Access, a fully open access peer-reviewed journal dedicated to publishing top research in the biomedical and biotechnology fields. For details, please visit the information for authors on the journal website.
*Please note that PubMedCentral, not the Publisher, has sole control over when the paper is made live on PMC.
Browse journals in the Liebert Open Access portfolio:
NIH Public Access Policy: In order to assist our authors who have NIH funding to comply with this policy, Mary Ann Liebert, Inc. publishers will deposit the final accepted paper (after copy-editing and proofreading) to PubMed Central (PMC) on behalf of the authors. Authors need not take any action. The manuscript's public access posting on PMC will occur 12 months after final publication. This service is provided free of charge. Please note that authors may not deposit manuscripts directly to PMC or other sites without permission from Mary Ann Liebert, Inc.
Publishing in Subscription Journals
By signing the copyright transfer statement, authors still retain a set of rights that allow for self-archiving.
Authors may archive their preprint manuscripts (version prior to peer review) at any time without restrictions. Authors may archive their postprint manuscripts (accepted version after peer review) in institutional repositories, preprint servers, and research networks after a 12 month embargo. The 12 month embargo period begins when the article is published online. Postprints must not be used for commercial purposes and acknowledgement must be given to the final publication, and publisher, by inserting the DOI number of the article in the following sentence: “Final publication is available from Mary Ann Liebert, Inc., publishers http://dx.doi.org/[insert DOI]”. Authors may archive on their personal website without an embargo provided their manuscript is updated with an acknowledgement to the publisher copyright and final published version.
The final published article (version of record) can never be archived in a repository, preprint server, or research network.
Publishing Open Access
Authors that wish to easily comply with funder or institutional open access mandates should consider publishing open access. Liebert Open Access option allows authors to make their research freely available online without restrictions. Additionally, Liebert Open Access option allows authors to retain copyright, archive and share the final published version of their article without restrictions. To publish open access please email firstname.lastname@example.org or visit Liebert Open Access for more information.